Prestige Consumer Healthcare’s (PBH) Free Cash Flow to Enterprise Value Stood at 6.5%

1 hour ago 1

Soumya Eswaran

Wed, March 25, 2026 astatine 8:38 AM CDT 4 min read

Heartland Advisors, an concern absorption company, released its “Heartland Opportunistic Value Equity Strategy” fourth-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. Large- and mega-cap stocks posted different 4th of outperformance successful Q4, contempt a little broad-based show crossed marketplace caps. The Russell 2000® Index of tiny stocks returned 2.19% successful the quarter, lagging the 2.66% summation for the S&P 500. The marketplace remains uncertain connected the definitive semipermanent winners from the proliferation of AI. To navigate economical uncertainty, the strategy adheres to its 10 Principles of Value Investing by focusing connected attractively priced, financially sound, and well-managed businesses that tin turn intrinsic value. The Strategy returned 0.79% during the quarter, trailing the Russell 3000® Value Index’s 3.78% return. The Strategy remains optimistic astir the market's enlargement and opportunities for growth. However, the caller volatility successful AI trends highlights the request to measure aggregate outcomes. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Heartland Opportunistic Value Equity Strategy highlighted Prestige Consumer Healthcare Inc. (NYSE:PBH). Prestige Consumer Healthcare Inc. (NYSE:PBH) is simply a starring shaper and distributor of over-the-counter (OTC) wellness and idiosyncratic attraction products. On March 24, 2026, Prestige Consumer Healthcare Inc. (NYSE:PBH) banal closed astatine $61.98 per share. One-month instrumentality of Prestige Consumer Healthcare Inc. (NYSE:PBH) was -10.64%, and its shares mislaid 27.06% implicit the past 52 weeks. Prestige Consumer Healthcare Inc. (NYSE:PBH) has a marketplace capitalization of $2.98 billion.

Heartland Opportunistic Value Equity Strategy stated the pursuing regarding Prestige Consumer Healthcare Inc. (NYSE:PBH) successful its 4th fourth 2025 capitalist letter:

"A caller mid-cap holding successful the 4th was Prestige Consumer Healthcare Inc. (NYSE:PBH), whose over-the-counter brands are acquainted to galore including Dramamine question sickness relief, Clear Eyes oculus drops, and CompoundW wart removal products among others. The banal had been a laggard, losing much than 30% since mid-May, acknowledgment to proviso concatenation issues related to its oculus attraction business. PBH’s supplier was simply not capable to vessel capable products to conscionable request for the company’s Clear Eyes business, causing Prestige to suffer income and little 2025 nett guidance.

Read Entire Article